Use of sugar in coffee, tea may not increase risk of incident diabetes or mortality Medha Baranwal23 Oct 2023 11:30 AM ISTDenmark: The use of sugar in coffee and/or tea was not significantly associated with increased risk of mortality or incident diabetes, a recent study...
Low serum desnutrin predicts insulin resistance in patients with vitiligo vulgaris Medha Baranwal23 Oct 2023 10:15 AM ISTEgypt: Low serum desnutrin could be a biomarker for insulin resistance in vitiligo vulgaris patients, says a recent study published in the Indian...
Study endorses use of closed-loop in type 1 diabetes associated with Pregnancy Dr. Kamal Kant Kohli23 Oct 2023 9:30 AM ISTA new study endorses closed-loop use in type 1 diabetes pregnancy and highlights how the technology can facilitate positive pregnancy experiences. The...
Red meat intake tied to increased risk of type 2 diabetes Dr. Kamal Kant Kohli21 Oct 2023 11:30 AM ISTUSA: Findings from a new study published in The American Journal of Clinical Nutrition support current dietary recommendations for limiting red meat...
Dapagliflozin or saxagliptin, which is better for children with type 2 diabetes? Medha Baranwal21 Oct 2023 11:15 AM ISTUSA: A phase III T2NOW trial comparing dapagliflozin or saxagliptin in pediatric type 2 diabetes revealed that Dapagliflozin (Farxiga) lowered HbA1c...
Teplizumab Shows Promise in Preserving Beta-Cells in Early Type 1 Diabetes: PROTECT Trial Results Dr Riya Dave21 Oct 2023 10:00 AM ISTIn a recent study, researchers have found that early administration of teplizumab, marketed as Tzield, may help preserve beta-cells in individuals...
Even low doses of radiation may contribute to diabetes shows Study from Fukushima Dr. Kamal Kant Kohli20 Oct 2023 8:00 PM ISTNew research to be presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Hamburg (2-6 Oct), suggests...
Fotagliptin, potential new approach for treatment-naive patients with type 2 diabetes Medha Baranwal20 Oct 2023 11:30 AM ISTChina: A recent study published in BMC Medicine revealed Fotagliptin, a novel DPP4 inhibitor, to be noninferior to alogliptin and significantly more...
Rosuvastin bests atorvastatin for cholesterol lowering with more risk of developing diabetes: BMJ Dr. Kamal Kant Kohli20 Oct 2023 11:15 AM ISTKorea: A secondary analysis of the randomised LODESTAR trial evaluated the rosuvastatin versus atorvastatin treatment in adults with coronary artery...
Commonly prescribed statin increases risk of type 2 diabetes, finds BMJ study Isra Zaman20 Oct 2023 9:15 AM ISTTwo widely used statins, rosuvastatin and atorvastatin, are equally effective at preventing heart attacks, strokes and death in people with coronary...
Earlier Onset of Puberty on the rise among Children with Type 1 Diabetes Jacinthlyn Sylvia20 Oct 2023 9:15 AM ISTA recent study conducted by the German Diabetes Prospective Follow-up (DPV) registry found the trends and factors associated with the onset of puberty...
High triglyceride glucose index in latent autoimmune diabetes linked with severe CKD Dr. Shravani Dali19 Oct 2023 11:30 AM ISTHigh triglyceride glucose index in latent autoimmune diabetes linked with severe CKD suggests a new study published in the BMC Endocrine...
